SK
AGN

Seth Klarman’s Allergan plc AGN Stock Holding History

Seth Klarman’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,679,549
Closed -$616M – 35
2019
Q2 		$616M Sell
3,679,549
-1,090,146
-23% -$151M 5.58% 6
2019
Q1 		$698M Buy
4,769,695
+14,200
+0.3% +$2.06M 5.87% 7
2018
Q4 		$636M Sell
4,755,495
-194,505
-4% -$31.9M 5.52% 6
2018
Q3 		$943M Hold
4,950,000
– – 7.22% 3
2018
Q2 		$825M Buy
4,950,000
+200,000
+4% +$32.1M 7.22% 6
2018
Q1 		$799M Buy
4,750,000
+250,000
+6% +$41.9M 7.71% 5
2017
Q4 		$736M Buy
4,500,000
+1,535,797
+52% +$276M 7.28% 6
2017
Q3 		$608M Buy
2,964,203
+531,600
+22% +$124M 7.57% 5
2017
Q2 		$591M Hold
2,432,603
– – 6.76% 5
2017
Q1 		$581M Sell
2,432,603
-1,000,000
-29% -$233M 6.84% 6
2016
Q4 		$721M Buy
3,432,603
+1,430,625
+71% +$296M 9.4% 4
2016
Q3 		$461M Hold
2,001,978
– – 6.55% 4
2016
Q2 		$463M Buy
2,001,978
+280,391
+16% +$64.6M 6.28% 4
2016
Q1 		$461M Buy
+1,721,587
New +$493M 6.66% 5

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Seth Klarman's AGN Position: Q3 2019 in Review

Seth Klarman sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 3,679,549 shares — an estimated $616M sold.

Seth Klarman first reported a position in AGN in Q1 2016 and held it in 14 quarters. The position peaked at $943M in Q3 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Seth Klarman reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Seth Klarman sold 3,679,549 Allergan plc shares in Q3 2019, an estimated $616M.
  • Seth Klarman first reported a position in Allergan plc in Q1 2016 and held it in 14 quarters.
  • Seth Klarman's Allergan plc position peaked at $943M in Q3 2018.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Baupost Group's 13F filing for Q3 2019, filed 13 Nov 2019.